139 related articles for article (PubMed ID: 28937237)
1. Selective inhibition of NF-kappaB and surfactant therapy in experimental meconium-induced lung injury.
Kopincova J; Mikolka P; Kolomaznik M; Kosutova P; Calkovska A; Mokra D
Physiol Res; 2017 Sep; 66(Suppl 2):S227-S236. PubMed ID: 28937237
[TBL] [Abstract][Full Text] [Related]
2. N-acetylcysteine advancement of surfactant therapy in experimental meconium aspiration syndrome: possible mechanisms.
Kopincová J; Mokrá D; Mikolka P; Kolomazník M; Čalkovská A
Physiol Res; 2014; 63(Suppl 4):S629-42. PubMed ID: 25669694
[TBL] [Abstract][Full Text] [Related]
3. Selective NF-kappaB inhibition, but not dexamethasone, decreases acute lung injury in a newborn piglet airway inflammation model.
von Bismarck P; Klemm K; García Wistädt CF; Winoto-Morbach S; Schütze S; Krause MF
Pulm Pharmacol Ther; 2009 Aug; 22(4):297-304. PubMed ID: 19254776
[TBL] [Abstract][Full Text] [Related]
4. Effects of surfactant/budesonide therapy on oxidative modifications in the lung in experimental meconium-induced lung injury.
Mikolka P; Kopincova J; Tomcikova Mikusiakova L; Kosutova P; Antosova M; Calkovska A; Mokra D
J Physiol Pharmacol; 2016 Feb; 67(1):57-65. PubMed ID: 27010895
[TBL] [Abstract][Full Text] [Related]
5. Anti-IL-8 antibody potentiates the effect of exogenous surfactant in respiratory failure caused by meconium aspiration.
Mikolka P; Kopincova J; Kosutova P; Kolomaznik M; Calkovska A; Mokra D
Exp Lung Res; 2018 Feb; 44(1):40-50. PubMed ID: 29324051
[TBL] [Abstract][Full Text] [Related]
6. Modified porcine surfactant enriched by recombinant human superoxide dismutase for experimental meconium aspiration syndrome.
Kopincova J; Mikolka P; Kolomaznik M; Kosutova P; Calkovska A; Mokra D
Life Sci; 2018 Jun; 203():121-128. PubMed ID: 29684443
[TBL] [Abstract][Full Text] [Related]
7. Recombinant Human Superoxide Dismutase and
Kopincova J; Kolomaznik M; Mikolka P; Kosutova P; Topercerova J; Matasova K; Calkovska A; Mokra D
Molecules; 2019 Mar; 24(5):. PubMed ID: 30841517
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of synthetic surfactant (CHF5633) bolus and/or lavage in meconium-induced lung injury in ventilated newborn rabbits.
Xu Y; Guo X; Chen M; Ricci F; Salomone F; Murgia X; Sun B
Pediatr Res; 2023 Feb; 93(3):541-550. PubMed ID: 35701606
[TBL] [Abstract][Full Text] [Related]
9. Bronchoalveolar lavage with pulmonary surfactant/dextran mixture improves meconium clearance and lung functions in experimental meconium aspiration syndrome.
Calkovska A; Mokra D; Drgova A; Zila I; Javorka K
Eur J Pediatr; 2008 Aug; 167(8):851-7. PubMed ID: 17952467
[TBL] [Abstract][Full Text] [Related]
10. Lung inflammatory and oxidative alterations after exogenous surfactant therapy fortified with budesonide in rabbit model of meconium aspiration syndrome.
Mikolka P; Kopincová J; Košútová P; Čierny D; Čalkovská A; Mokrá D
Physiol Res; 2016 Dec; 65(Suppl 5):S653-S662. PubMed ID: 28006947
[TBL] [Abstract][Full Text] [Related]
11. Antiinflammatory Effect of N-Acetylcysteine Combined with Exogenous Surfactant in Meconium-Induced Lung Injury.
Mikolka P; Kopincova J; Mikusiakova LT; Kosutova P; Calkovska A; Mokra D
Adv Exp Med Biol; 2016; 934():63-75. PubMed ID: 27283193
[TBL] [Abstract][Full Text] [Related]
12. [Effects of combined surfactant and inhaled nitric oxide in ventilated rabbits with meconium aspiration-induced acute lung injury].
Hu XW; Zhu YR; Lu Y; Lam LK; Zhang LE; Shao XM; Sun B
Zhonghua Er Ke Za Zhi; 2003 Oct; 41(10):761-5. PubMed ID: 14731358
[TBL] [Abstract][Full Text] [Related]
13. Treatment of experimental meconium aspiration syndrome with surfactant lung lavage and conventional vs. asymmetric high-frequency jet ventilation.
Sevecova-Mokra D; Calkovska A; Drgova A; Javorka M; Javorka K
Pediatr Pulmonol; 2004 Oct; 38(4):285-91. PubMed ID: 15334504
[TBL] [Abstract][Full Text] [Related]
14. Surfactant therapy for meconium aspiration syndrome: current status.
Dargaville PA; Mills JF
Drugs; 2005; 65(18):2569-91. PubMed ID: 16392874
[TBL] [Abstract][Full Text] [Related]
15. Combined effects of high-frequency ventilation and surfactant treatment in experimental meconium aspiration syndrome.
Calkovska A; Sun B; Curstedt T; Renheim G; Robertson B
Acta Anaesthesiol Scand; 1999 Feb; 43(2):135-45. PubMed ID: 10027019
[TBL] [Abstract][Full Text] [Related]
16. Surfactant lavage decreases systemic interleukin-1 beta production in meconium aspiration syndrome.
Wang PW; Jeng MJ; Wang LS; Fang LJ; Soong WJ
Pediatr Int; 2010 Jun; 52(3):432-7. PubMed ID: 19919635
[TBL] [Abstract][Full Text] [Related]
17. Mitigation of meconium-induced lung injury by surfactant and inhaled nitric oxide is associated with suppression of nuclear transcription factor kappa B.
Hu X; Cao L; Lam LK; Zhu L; Guo C; Sun B
Biol Neonate; 2005; 87(2):73-81. PubMed ID: 15692188
[TBL] [Abstract][Full Text] [Related]
18. Surfactant "fortification" by topical inhibition of nuclear factor-kappaB activity in a newborn piglet lavage model.
von Bismarck P; Klemm K; Wistädt CF; Winoto-Morbach S; Uhlig U; Schütze S; Uhlig S; Lachmann B; Krause MF
Crit Care Med; 2007 Oct; 35(10):2309-18. PubMed ID: 17944019
[TBL] [Abstract][Full Text] [Related]
19. Surfactant lung lavage using asymmetric high-frequency jet ventilation followed by conventional ventilation in rabbits with meconium aspiration.
Mokra D; Calkovska A; Drgova A; Javorka K
Bratisl Lek Listy; 2005; 106(12):412-5. PubMed ID: 16642667
[TBL] [Abstract][Full Text] [Related]
20. Anti-inflammatory treatment in dysfunction of pulmonary surfactant in meconium-induced acute lung injury.
Mokra D; Drgova A; Kopincova J; Pullmann R; Calkovska A
Adv Exp Med Biol; 2013; 756():189-96. PubMed ID: 22836635
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
